Ripple mapping: A precise tool for atrioventricular nodal reentrant tachycardia ablation

J Cardiovasc Electrophysiol. 2022 Jun;33(6):1183-1189. doi: 10.1111/jce.15491. Epub 2022 Apr 28.

Abstract

Introduction: Ablation for atrioventricular nodal reentrant tachycardia (AVNRT) classically utilizes evaluation of signal morphology within the anatomic region of the slow pathway (SP), which involves subjectivity. Ripple mapping (RM; CARTO-3© Biosense Webster Inc) displays each electrogram at its three-dimensional coordinate as a bar changing in length according to its voltage-time relationship. This allows prolonged, low-amplitude signals to be displayed in their entirety, helping identify propagation in low-voltage areas. We set out to evaluate the ability of RM to locate the anatomic site of the SP and assess its use in guiding ablation for AVNRT.

Methods: Patients ≤18 years with AVNRT in the EP laboratory between 2017 and 2021 were evaluated. RM was performed to define region of SP conduction in patients from 2019 to 2021, whereas standard electro-anatomical mapping was used from 2017 to 2019. All ablations were performed using cryotherapy. Demographics, outcomes, and analysis of variance in number of test lesions until success was compared between groups.

Results: A total of 115 patients underwent AVRNT ablation during the study; 46 patients were in the RM group and 69 were in the control group. There were no demographic differences between groups. All procedures, in both groups, were acutely successful. In RM group, 89% of first successful lesions were within 4 mm of the predicted site. There was significantly reduced variability in number of test lesions until success in the RM group (p = .01).

Conclusion: RM is a novel technique that can help identify SP location, allowing for successful ablation of AVNRT with decreased variability.

Keywords: 3D mapping; AVNRT; SVT; ablation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / methods
  • Heart Rate
  • Humans
  • Tachycardia, Atrioventricular Nodal Reentry* / diagnosis
  • Tachycardia, Atrioventricular Nodal Reentry* / surgery
  • Time Factors
  • Treatment Outcome